Displaying results 1 - 1 of 1
-
Utilizing the 'Crowd Trial' for Pharmacovigilance: a case report
Content Type: Abstract
Singulair (MONTELUKAST SODIUM) is a Leukotriene receptor antagonist, indicated to prevent asthma attacks in adults and children. It is also used to relieve allergies in adults and children. Singulair was approved by the FDA in February 20, 1998. In… read more… across more than 150,000 (and growing) English-language sites, forums and blogs. FLR has searched and mapped thousands of these sites and indexed hundreds of millions of posts (currently …

